Literature DB >> 24930792

Urinary incontinence in schizophrenic patients treated with atypical antipsychotics: urodynamic findings and therapeutic perspectives.

Diletta La Torre1, Sandra Isgrò, Maria Rosaria Anna Muscatello, Carlo Magno, Darwin Melloni, Mario Meduri.   

Abstract

Objective The present study was a urodynamic evaluation of schizophrenic patients with urinary incontinence occurring during treatment with atypical antipsychotics Methods A total of 12 schizophrenic patients (mean age = 30.7 years, SD = 6.5) presenting urinary incontinence during treatment with atypical antipsychotics at stable doses underwent urodynamic evaluations. Clinical assessment included the administration of Positive and Negative Syndrome Scale (PANSS) Results Four patients out of 12 presented urodynamic patterns consistent with an overactive bladder, while five patients presented reduced bladder compliance; only three patients showed normal urodynamic patterns Conclusion Detrusor overactivity is a condition associated with urinary incontinence in schizophrenic patients treated with atypical antipsychotics. Urodynamic evaluations can improve our knowledge of the mechanisms that subtend atypical antipsychotic-induced incontinence, an invalidating side-effect with strong repercussion on compliance and rehabilitation in schizophrenic patients.

Entities:  

Keywords:  Schizophrenia; atypical antipsychotics; detrusor overactivity; urinary incontinence

Year:  2005        PMID: 24930792     DOI: 10.1080/13651500510018329

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  2 in total

1.  Risperidone-induced enuresis in an adult.

Authors:  Tanvir Singh; Theodor Rais; Alina Rais
Journal:  Psychiatry (Edgmont)       Date:  2007-01

2.  An exploratory study for bladder dysfunction in atypical antipsychotic-emergent urinary incontinence.

Authors:  Preeti Sinha; Anupam Gupta; V Senthil Kumar Reddi; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2016 Oct-Dec       Impact factor: 1.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.